Cite
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
MLA
Jun Chen, et al. “A TRPA1 Inhibitor Suppresses Neurogenic Inflammation and Airway Contraction for Asthma Treatment.” Journal of Experimental Medicine, vol. 218, Feb. 2021. EBSCOhost, https://doi.org/10.1084/jem.20201637.
APA
Jun Chen, Justin Elstrott, Lan Wang, Simon S. Gao, Richard A.D. Carano, Jose E. Heredia, Elisia Villemure, Daniel G. Shore, Wyne P. Lee, Bobby Brillantes, Joseph H. Lin, Liling Liu, David H. Hackos, Jens Kortmann, Matthew Volgraf, Daniel D. Bravo, Christine Tam, Lorena Riol-Blanco, Steven Magnuson, … Bianca M. Liederer. (2021). A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment. Journal of Experimental Medicine, 218. https://doi.org/10.1084/jem.20201637
Chicago
Jun Chen, Justin Elstrott, Lan Wang, Simon S. Gao, Richard A.D. Carano, Jose E. Heredia, Elisia Villemure, et al. 2021. “A TRPA1 Inhibitor Suppresses Neurogenic Inflammation and Airway Contraction for Asthma Treatment.” Journal of Experimental Medicine 218 (February). doi:10.1084/jem.20201637.